These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 9177679)

  • 1. Quantitative dynamic multicompartmental analysis of cholecystokinin receptor movement in a living cell using dual fluorophores and reconstruction of confocal images.
    Go WY; Roettger BF; Holicky EL; Hadac EM; Miller LJ
    Anal Biochem; 1997 May; 247(2):210-5. PubMed ID: 9177679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor.
    Harikumar KG; Pinon DI; Miller LJ
    Biosci Rep; 2006 Apr; 26(2):89-100. PubMed ID: 16779661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-resolved quantitative analysis of CCK1 receptor-induced intracellular calcium increase.
    Staljanssens D; De Vos WH; Willems P; Van Camp J; Smagghe G
    Peptides; 2012 Mar; 34(1):219-25. PubMed ID: 21352882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular handling of unoccupied and agonist-stimulated cholecystokinin receptor determined by immunolocalization.
    Fischer de Toledo C; Roettger BF; Morys-Wortmann C; Schmidt WE; Miller LJ
    Am J Physiol; 1997 Mar; 272(3 Pt 1):G488-97. PubMed ID: 9124569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
    Harikumar KG; Pinon DI; Wessels WS; Dawson ES; Lybrand TP; Prendergast FG; Miller LJ
    Mol Pharmacol; 2004 Jan; 65(1):28-35. PubMed ID: 14722234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor.
    Ghanekar D; Hadac EM; Holicky EL; Miller LJ
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1206-12. PubMed ID: 9316827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular localization and pharmacological characterization of functioning alpha-1 adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors.
    Daly CJ; Milligan CM; Milligan G; Mackenzie JF; Mcgrath JC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):984-90. PubMed ID: 9694959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerted action of cytosolic Ca2+ and protein kinase C in receptor-mediated phospholipase D activation in Chinese hamster ovary cells expressing the cholecystokinin-A receptor.
    Bosch RR; Smeets RL; Sleutels F; Patel AM; Emst-de Vries SE; Joep J; de Pont HH; Willems PH
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):263-8. PubMed ID: 9882623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
    Arlander SJ; Dong M; Ding XQ; Pinon DI; Miller LJ
    Mol Pharmacol; 2004 Sep; 66(3):545-52. PubMed ID: 15322246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
    Hadac EM; Ji Z; Pinon DI; Henne RM; Lybrand TP; Miller LJ
    J Med Chem; 1999 Jun; 42(12):2105-11. PubMed ID: 10377216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual pathways of internalization of the cholecystokinin receptor.
    Roettger BF; Rentsch RU; Pinon D; Holicky E; Hadac E; Larkin JM; Miller LJ
    J Cell Biol; 1995 Mar; 128(6):1029-41. PubMed ID: 7896869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell.
    Roettger BF; Rentsch RU; Hadac EM; Hellen EH; Burghardt TP; Miller LJ
    J Cell Biol; 1995 Aug; 130(3):579-90. PubMed ID: 7622559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin-induced desensitization, receptor phosphorylation, and internalization in the CHP212 neuroblastoma cell line.
    Rao RV; Hadac EM; Roettger BF; Miller LJ
    J Neurochem; 1997 Jun; 68(6):2356-62. PubMed ID: 9166728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites.
    Mackenzie JF; Daly CJ; Pediani JD; McGrath JC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):434-43. PubMed ID: 10900216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion delays and unstirred layer effects at monolayer cultures of Chinese hamster ovary cells: radioligand binding, confocal microscopy, and mathematical simulations.
    Spivak CE; Oz M; Beglan CL; Shrager RI
    Cell Biochem Biophys; 2006; 45(1):43-58. PubMed ID: 16679563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative image analysis of cellular protein translocation induced by magnetic microspheres: application to the EGF receptor.
    Brock R; Jovin TM
    Cytometry A; 2003 Mar; 52(1):1-11. PubMed ID: 12596246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.